Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster...

por Kovac, Martina, Kostanyan, Lusiné, Mesaros, Narcisa, Kuriyakose, Sherine, Varman, Meera
Publicado 2018

LB745. Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults ≥ 60 Years of Age (YOA)

por Ison, Michael G, Papi, Alberto, Langley, Joanne M, Lee, Dong-Gun, Leroux-Roels, Isabel, Martinon-Torres, Federico, Schwarz, Tino F, Van Zyl-Smit, Richard N, Dezutter, Nancy, De Schrevel, Nathalie, Fissette, Laurence, David, Marie-Pierre, Van Der Wielen, Marie, Kostanyan, Lusine, Hulstrøm, Veronica
Publicado 2022